MX9709904A - Formulaciones de hidroxiapatita biocompatibles y usos de las mismas. - Google Patents

Formulaciones de hidroxiapatita biocompatibles y usos de las mismas.

Info

Publication number
MX9709904A
MX9709904A MX9709904A MX9709904A MX9709904A MX 9709904 A MX9709904 A MX 9709904A MX 9709904 A MX9709904 A MX 9709904A MX 9709904 A MX9709904 A MX 9709904A MX 9709904 A MX9709904 A MX 9709904A
Authority
MX
Mexico
Prior art keywords
additive
formulation
liquid phase
biocompatible
uses therefor
Prior art date
Application number
MX9709904A
Other languages
English (en)
Other versions
MXPA97009904A (es
Inventor
Peter D Constantino
Craig D Friedman
Sen Arup
Original Assignee
Osteogenics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osteogenics Inc filed Critical Osteogenics Inc
Publication of MX9709904A publication Critical patent/MX9709904A/es
Publication of MXPA97009904A publication Critical patent/MXPA97009904A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/02—Surgical adhesives or cements; Adhesives for colostomy devices containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/12—Phosphorus-containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/30—Inorganic materials
    • A61L27/32—Phosphorus-containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005—The prosthesis being constructed from a particular material
    • A61F2310/00179—Ceramics or ceramic-like structures
    • A61F2310/00293—Ceramics or ceramic-like structures containing a phosphorus-containing compound, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00389—The prosthesis being coated or covered with a particular material
    • A61F2310/00592—Coating or prosthesis-covering structure made of ceramics or of ceramic-like compounds
    • A61F2310/00796—Coating or prosthesis-covering structure made of a phosphorus-containing compound, e.g. hydroxy(l)apatite

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se provee una formulacion de hidroxiapatita biocompatible; la formulacion se precipita de una mezcla de una fase líquida, un aditivo bioactivo o biocompatible que puede ser cualquiera de un numero de substancias bioreactivas u otras, y una combinacion de base de sales de fosfato de calcio; la fase líquida y el aditivo pueden combinarse para producir una fase líquida aumentada, que se mezcla después con la combinacion de sal de base; el aditivo se elige para lograr un efecto deseado durante la administracion de la formulacion a una planta o animal; el aditivo se libera en el lugar fisiologico que rodea y se reabsorbe el componente de hidroxiapatita.
MXPA/A/1997/009904A 1995-06-06 1997-12-08 Formulaciones de hidroxiapatita biocompatibles y usos de las mismas MXPA97009904A (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US471216 1990-01-26
US46808495A 1995-06-06 1995-06-06
US46990995A 1995-06-06 1995-06-06
US47121695A 1995-06-06 1995-06-06
US469909 1995-06-06
US468084 1995-06-06

Publications (2)

Publication Number Publication Date
MX9709904A true MX9709904A (es) 1998-08-30
MXPA97009904A MXPA97009904A (es) 1998-11-12

Family

ID=

Also Published As

Publication number Publication date
CA2223596A1 (en) 1996-12-12
AU6149696A (en) 1996-12-24
AU723740B2 (en) 2000-09-07
EP0830149A1 (en) 1998-03-25
JPH11506659A (ja) 1999-06-15
WO1996039202A1 (en) 1996-12-12
BR9608344A (pt) 1999-01-05

Similar Documents

Publication Publication Date Title
US5782971B1 (en) Calcium phosphate cements comprising amorophous calcium phosphate
GR3024277T3 (en) Tgf-beta formulation for inducing bone growth.
CA2079831A1 (en) Biodegradable polymer composition
GR3034921T3 (en) Tissue treatment composition comprising fibrin or fibrinogen and biodegradable and biocompatible polymer.
IL115721A0 (en) Methods and compositions for the modulation of cell proliferation and wound healing
PL334348A1 (en) Method of treating prostate diseases using vitamin d formulations of retarded and/or prolonged release
UA29563C2 (uk) Мікрокапсула для тривалого вивільнення фізіологічно активного пептиду
IL111647A0 (en) Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles, their preparation and pharmaceutical compositions containing them
ATE228481T1 (de) Verfahren zur herstellung eines hydroxyapatit enthaltendes biomaterials, hergestelltes biomaterial und chirurgische oder zahnärtzlische anwendung
NZ328898A (en) Sustained release formulation containing collagen and glycosaminoglycan additives
EP0804595A4 (es)
ZA875897B (en) Estradiol implant composition and method for preparation
CA2121674A1 (en) Biocompatible implant for the timing of ovulation in mares
CA2274787A1 (en) Preparation, storage and administration of cements
ZA947338B (en) Use of angiotensin II and analogs thereof in tissue repair
CA2251281A1 (en) Drug composition with controlled drug release rate
CA2198099A1 (en) Use of tasteless, hydrolysed collagen and agent containing the same
DE69501419D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von Osteoporose enthaltend Xanthohumol
IL115138A0 (en) Implantable polymer-containing molded articles for the administration of active substances to plants and processes for the preparation thereof
IL134268A0 (en) Pharmaceutical compositions containing vitamin d and calcium, their preparation and therapeutic use
JPS6434916A (en) Medicinal composition for treating uremia
CA2073453A1 (en) Methods of enhancing wound healing and tissue repair
MX9709904A (es) Formulaciones de hidroxiapatita biocompatibles y usos de las mismas.
GEP20032906B (en) Controlled Release Peroral Pharmaceutical Composition of Levosimendan for Treatment of Congestive Heart Failure
FR2668367B1 (fr) Medicament implantable a effet prolonge.